TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Received Notice of Non-Compliance with NYSE MKT

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2015-12-02
Original SEC Filing: Click here


Webplus: TPI/20151202/8-K/2_EX-99.1/000.htm SEC Original: f8k112515ex99i_tianyin.htm
TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements Tianyin Pharmaceutical Inc. (NYSE Amex: TPI) (the “Company”), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), received notice on November 25, 2015 from the NYSE MKT LLC (the “Exchange”) indicating that the Company is below certain




Webplus: TPI/20151202/8-K/1/000.htm SEC Original: f8k112515_tianyin.htm



Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2015-12-02CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041

Home Page Forums

By | 2016-03-19T14:00:33+00:00 December 2nd, 2015|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar